医学
急性胰腺炎
内科学
胰腺炎
胃肠病学
重症监护医学
坏死
作者
Nikhil R. Thiruvengadam,Janille Miranda,Christopher Kim,Spencer C. Behr,Mustafa Arain
出处
期刊:Pancreas
[Ovid Technologies (Wolters Kluwer)]
日期:2021-07-01
卷期号:50 (6): 859-866
被引量:6
标识
DOI:10.1097/mpa.0000000000001838
摘要
Objectives The Pancreatitis Activity Scoring System (PASS) is an objective tool validated in acute pancreatitis but not in infected pancreatic necrosis (IPN). Our aim was to evaluate the role of PASS in IPN. Methods We performed a retrospective cohort study of IPN patients admitted to the University of California, San Francisco from January 2011 to March 2019. Daily PASS scores were calculated for each patient. Receiver operator characteristic analysis was used to define the optimal cutoff PASS score to predict outcomes. The primary and secondary outcomes were 72 hours postintervention multiorgan failure (MOF) and early readmission (within 30 days), respectively. Results One hundred and four patients underwent intervention (median age, 55 years). Thirty-five patients (33.6%) developed MOF postintervention. A 72-hour postintervention PASS greater than 250 was strongly associated with postintervention MOF (area under curve, 0.87; adjusted odds ratio, 26.83; 95% confidence interval, 6.37–112.86; P < 0.001). Discharge PASS greater than 150 was associated with 30-day readmission (area under curve, 0.82; adjusted odds ratio, 26.44; 95% confidence interval, 8.48–82.43; P < 0.001). Conclusions The PASS score was associated with postintervention clinical outcomes and early readmission, suggesting it is a valid measure of disease activity in patients with IPN. Further prospective validation of PASS in IPN is needed.
科研通智能强力驱动
Strongly Powered by AbleSci AI